Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 707-711

  Di Pentima, M Cecilia ^a,b   Chan, Shannon ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

antimicrobial stewardship; pediatrics; vancomycin

Indexed keywords

CEFAZOLIN; CEFEPIME; CLINDAMYCIN; COTRIMOXAZOLE; LINEZOLID; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHILD; DRUG INDICATION; DRUG USE; ENTEROCOCCAL INFECTION; FEMALE; GRAM POSITIVE INFECTION; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MANDATORY PROGRAM; MEDICAL INFORMATION SYSTEM; MEDICATION ERROR; NEWBORN; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; BACTERIAL INFECTIONS; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; FACTUAL DATABASE; HOSPITAL; POLICY; STANDARDS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, PEDIATRIC; HOSPITALS, TEACHING; HUMANS; INFANT; INFANT, NEWBORN; MALE; ORGANIZATIONAL POLICY; VANCOMYCIN; YOUNG ADULT;

EID: 77955129489     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d683f8     Document Type: Article

References (32)

1. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(suppl 2):S114-S132.
2. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342:710-721.
3. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21:510-515.
4. Lessa FC, Edwards JR, Fridkin SK, et al. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J. 2009;28:577-581.
5. Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis. 2009;49:65-71.
6. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother. 2005;56:455-462.
7. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182.
8. Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42:389-391.
9. Nolan SM, Gerber JS, Zaoutis T, et al. Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients. Infect Control Hosp Epidemiol. 2009;30:338-345.
10. Pallares R, Dick R, Wenzel RP, et al. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978-1992). Infect Control Hosp Epidemiol. 1993;14:376-382.
11. Finks J, Wells E, Dyke TL, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis. 2009;15:943-945.
12. Rosenberg J, Jarvis WR, Abbott SL, et al. Emergence of vancomycinresistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infect Control Hosp Epidemiol. 2004;25:408-412.
13. Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 1995;16:634-637.
14. Rubin LG, Tucci V, Cercenado E, et al. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992;13:700-705.
15. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.
16. From the Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States 1989-1993. JAMA. 1993;270:1796.
17. Centers for Disease Control and Prevention (CDC). Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42:597-599.
18. Singh-Naz N, Sleemi A, Pikis A, et al. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol. 1999;37:413-416
19. Alliance for the Prudent Use of Antibiotics. Executive summary: select findings, conclusions, and policy recommendations. Clin Infect Dis. 2005; 41(suppl 4):S224-S227.
20. Bolon MK, Arnold AD, Feldman HA, et al. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatr Infect Dis J. 2005;24:1053-1058.
21. Shah SS, Sinkowitz-Cochran RL, Keyserling HL, et al. Vancomycin use in pediatric neurosurgery patients. Am J Infect Control. 1999;27:482-487.
22. Kahyaoglu O, Akpinar M, Nolan B, et al. Vancomycin use and monitoring in pediatric patients in a community hospital. Infect Control Hosp Epidemiol. 1998;19:299-301.
23. Thomas AR, Cieslak PR, Strausbaugh LJ, et al. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a populationbased assessment. Infect Control Hosp Epidemiol. 2002;23:683-688.
24. Anglim AM, Klym B, Byers KE, et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med. 1997;157:1132-1136.
25. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
26. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18:638-656.
27. Patel SJ, Larson EL, Kubin CJ, et al. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26:531-537.
28. Agwu AL, Lee CK, Jain SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis. 2008;47:747-753.
29. Metjian TA, Prasad PA, Kogon A, et al. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27:106-111.
30. Samore MH, Bateman K, Alder SC, et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA. 2005;294:2305-2314.
31. Thursky K. Use of computerized decision support systems to improve antibiotic prescribing. Expert Rev Anti Infect Ther. 2006;4:491-507.
32. Di Pentima MC, Chan S, Eppes SC, et al. Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection and intervention. Clin Pediatr (Phila). 2009;48:505-512.